Testosterone
Key facts
Active substance |
Testosterone
|
Therapeutic area |
Endocrinology, -gynacology-fertility-metabolism
|
Decision number |
P/161/2009
|
PIP number |
Testosterone
|
Pharmaceutical form(s) |
Transdermal patch
|
Condition(s) / indication(s) |
Hypoactive sexual desire disorder
|
Route(s) of administration |
Transdermal use
|
Contact for public enquiries |
Procter & Gamble Pharmaceuticals UK Ltd
|
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|